Infinity Pharmaceuticals Inc (NASDAQ:INFI)

0.1926
Delayed Data
As of Mar 24
 +0.0006 / +0.31%
Today’s Change
0.17
Today|||52-Week Range
1.76
-65.30%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$17.4M

Company Description

Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development segment. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.

Contact Information

Infinity Pharmaceuticals, Inc.
1100 Massachusetts Avenue
Cambridge Massachusetts 02138
P:(617) 453-1000
Investor Relations:

Employees

Shareholders

Individual stakeholders22.53%
Other institutional19.15%
Mutual fund holders11.12%

Top Executives

Adelene Q. PerkinsChairman & Chief Executive Officer
Lawrence E. BlochPresident & Treasurer
Melissa HackelVice President-Finance
Stephane PelusoChief Scientific Officer
Robert IlariaChief Medical Officer